AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EMTRICITABINE; TENOFOVIR ALAFENAMIDE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EMTRICITABINE; TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 2021/7.13/6213 | CIPLA LTD | active | 22 Oct 2029 |
| EMTRICITABINE; TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 2018/7.13/5740 | MYLAN LABORATORIES LIMITED | active | 28 Aug 2029 |
| EMTRICITABINE ; TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 2023/7.13/6485 | LAURUS LABS LIMITED | active | 4 Oct 2028 |
| EMTRICITABINE; TENOFOVIR ALAFENAMIDE TABLET, COATED; ORAL | 2023/7.13/6382 | HETERO LABS LTD | active | 22 Feb 2028 |
| DESCOVY TABLET, COATED; ORAL | 2017/7.13/5445 | GILEAD SCIENCES INC | active | 31 Dec 2027 |
EMTRICITABINE; TENOFOVIR ALAFENAMIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing EMTRICITABINE; TENOFOVIR ALAFENAMIDE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EMTRICITABINE; TENOFOVIR ALAFENAMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.